Cortizone-10 Products
Allegations: Misleadingly marketing products as “Maximum Strength”
Cortizone-10
Case Name (Date)
Thompson et al. v. Chattem, Inc.
23-cv-3073, N.D. Cal.
(June 2023)
Product/Service
Cortizone-10
Allegations
Falsely marketing products with 1% hydrocortisone as “maximum strength” when other products contain higher concentrations of the ingredient
Status
Class-Action Tracker
ACT Dry Mouth Lozenges
Allegations: Failing to disclose that the product is detrimental to oral health due to having a pH level that is below the pH level of tooth enamel and root dentin
Unisom Simple Slumbers
Allegations: False natural claims
Dulcolax
Allegations: False natural claims
ACT Total Care Anticavity Fluoride Mouthwash
In July 2013, a federal judge granted final approval of a settlement agreement reached in a false advertising class-action lawsuit against Chattem, Inc. The complaint, which was originally filed in…
ACT Restoring Mouthwash
May 2015: A federal judge granted Chattem Inc.’s motion to dismiss finding that the claim was preempted by federal law. February 2015: A false advertising class-action lawsuit was filed against…
ACT® Restoring™ Anticavity Fluoride Mouthwash
February 2015: This action was dismissed for lack of subject matter jurisdiction. The dismissal was When a complaint is dismissed without prejudice, an amended version of the complaint can be…
The Latest
Aspercreme
TINA.org investigates after doctor challenges pain reliever’s “clinically proven” labeling claim on Twitter.
ACT Dry Mouth Mouthwash, Lozenges
NAD tells marketer to watch its mouth when it comes to making certain dry mouth product claims.
Nasacort
Makers of nasal allergy spray told to cease consumer preference claims.